We are live on ! Find out more
AIP

Arrowpoint Investment Partners Portfolio holdings

AUM $459M
1-Year Est. Return 93.97%
This Fund
S&P 500
This Quarter Est. Return
+33.31%
1 Year Est. Return
+93.97%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$459M
AUM Growth
+$347M
Cap. Flow
+$245M
Cap. Flow %
53.32%
Top 10 Hldgs %
63.7%
Holding
167
New
86
Increased
23
Reduced
20
Closed
38

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$30.6M
2
GS icon
Goldman Sachs
GS
+$30.2M
3
XOM icon
ExxonMobil
XOM
+$26.8M
4
GPN icon
Global Payments
GPN
+$26.4M
5
NVDA icon
NVIDIA
NVDA
+$25.8M

Sector Composition

Rank Sector Weight
1 Miscellaneous 28.72%
2 Healthcare 18.58%
3 Financials 14.08%
4 Industrials 12.67%
5 Technology 12.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMH icon
1
CALL
VanEck Semiconductor ETF
SMH
$69.2B
$52.5M 11.43%
+80,000
New +$43.6M
C icon
2
Citigroup
C
$229B
$32.9M 7.17%
+235,033
New +$30.6M
GS icon
3
Goldman Sachs
GS
$300B
$31.3M 6.82%
+30,971
New +$30.2M
SPY icon
4
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$815B
$29.9M 6.51%
+40,000
New +$29M
GPN icon
5
Global Payments
GPN
$24.4B
$27.9M 6.07%
+384,114
New +$26.4M
NSC icon
6
Norfolk Southern
NSC
$74.2B
$25.6M 5.57%
+81,332
New +$25.1M
AEP icon
7
American Electric Power
AEP
$68B
$25.4M 5.54%
+185,962
New +$24.5M
NVDA icon
8
NVIDIA
NVDA
$5.58T
$25.1M 5.47%
+125,539
New +$25.8M
XOM icon
9
ExxonMobil
XOM
$661B
$24.5M 5.34%
+179,273
New +$26.8M
EWY icon
10
PUT
iShares MSCI South Korea ETF
EWY
$28.4B
$17.3M 3.77%
+86,000
New +$15.2M
GOOGL icon
11
Alphabet (Google) Class A
GOOGL
$4.13T
$12.3M 2.69%
34,557
+3,430
+11% +$1.23M
EWT icon
12
PUT
iShares MSCI Taiwan ETF
EWT
$12.1B
$12.2M 2.65%
+112,000
New +$10.5M
MU icon
13
Micron Technology
MU
$1.13T
$7.52M 1.64%
+6,519
New +$4.89M
IGV icon
14
CALL
iShares Expanded Tech-Software Sector ETF
IGV
$14.1B
$7.25M 1.58%
80,000
-150,800
-65% -$13.4M
INTC icon
15
Intel
INTC
$501B
$4.66M 1.02%
+33,371
New +$3.37M
SNDK
16
Sandisk
SNDK
$247B
$4.57M 0.99%
+2,008
New +$2.87M
ARGX icon
17
argenx
ARGX
$65B
$4.07M 0.89%
+4,392
New +$3.62M
INFY icon
18
Infosys
INFY
$47.7B
$3.85M 0.84%
+367,077
New +$4.6M
CAT icon
19
Caterpillar
CAT
$374B
$3.77M 0.82%
+3,539
New +$3.11M
AXSM icon
20
Axsome Therapeutics
AXSM
$10.9B
$3.39M 0.74%
13,831
-2,570
-16% -$557K
INSM icon
21
Insmed
INSM
$27.8B
$3.22M 0.7%
30,170
+23,152
+330% +$2.8M
UNH icon
22
UnitedHealth
UNH
$356B
$3.18M 0.69%
7,657
+2,441
+47% +$905K
BRKR icon
23
Bruker
BRKR
$9.04B
$3.18M 0.69%
+52,780
New +$2.46M
MDGL icon
24
Madrigal Pharmaceuticals
MDGL
$12.6B
$3.15M 0.69%
5,865
+4,673
+392% +$2.39M
TVTX icon
25
Travere Therapeutics
TVTX
$6.2B
$3.13M 0.68%
+55,112
New +$2.44M

Similar funds

Arrowpoint Investment Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Arrowpoint Investment Partners held 167 positions worth $459M, up 308% from $113M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Arrowpoint Investment Partners deployed $245M of net new capital in Q2 2026, opening 86 new positions and adding to 23 existing holdings. Its largest new stake was Citigroup: 235,033 shares worth $32.9M.

By sector, the portfolio is most concentrated in Miscellaneous at 29% of assets, down from 45% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Ionis Pharmaceuticals, an estimated $2.01M trimmed.

  • Arrowpoint Investment Partners's largest Q2 2026 buy was Citigroup: 235,033 shares worth $32.9M.
  • Arrowpoint Investment Partners added most to Insmed in Q2 2026, an estimated $2.8M increase.
  • Arrowpoint Investment Partners's biggest Q2 2026 reduction was Ionis Pharmaceuticals, cutting an estimated $2.01M.
  • Arrowpoint Investment Partners fully exited ASE Group in Q2 2026, selling an estimated $3.89M.
  • Arrowpoint Investment Partners's ten largest holdings make up 64% of its $459M portfolio in Q2 2026.
  • Arrowpoint Investment Partners opened 86 new positions and closed 38 in Q2 2026.
  • Arrowpoint Investment Partners's portfolio value rose 308% quarter-over-quarter to $459M.

Based on Arrowpoint Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.